Prognostic Value of CTC in HNSCC Patients
NCT01884129 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 53
Last updated 2015-12-10
Summary
We hypothesized that the number of circulating tumor cells (CTCs) and molecular markers on CTCs could be a prognostic factor or predictive factor to patients with head neck cancer.
Conditions
- Recurrence
- Metastasis
- Death
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Principal Investigators
-
Chia-Hsun C Hsieh, M.D, M.S. · Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
NCT02567383 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
NCT01192750 ·Status: COMPLETED
-
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer
NCT05296135 ·Status: WITHDRAWN
-
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
NCT04086849 ·Status: COMPLETED
-
Change in Symptom Clusters in HNC Patients
NCT03356093 ·Status: COMPLETED
-
Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT04361409 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Improving End of Life Care in Head and Neck Cancer
NCT01632969 ·Status: TERMINATED
-
Evaluating the Use of an Informational Head and Neck Cancer Website.
NCT04268329 ·Status: TERMINATED ·Phase: NA
-
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
NCT00620139 ·Status: COMPLETED
-
A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC
NCT00483821 ·Status: COMPLETED
-
Reconstructive Surgery For Head And Neck Cancer Patients
NCT00578032 ·Status: COMPLETED
-
Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
NCT02943044 ·Status: UNKNOWN
-
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
NCT00713219 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01412229 ·Status: COMPLETED ·Phase: PHASE2
-
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
NCT02128906 ·Status: RECRUITING ·Phase: PHASE2
-
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
NCT01619618 ·Status: COMPLETED
-
Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences
NCT05801770 ·Status: NOT_YET_RECRUITING
-
WGA in Platinum-refractory HNSCC Underwent Nivolumab
NCT03917537 ·Status: UNKNOWN
-
Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas
NCT02279459 ·Status: COMPLETED
-
Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00805012 ·Status: TERMINATED ·Phase: PHASE2
-
A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
NCT04603248 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma
NCT02119559 ·Status: UNKNOWN ·Phase: NA
-
PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
NCT03163797 ·Status: UNKNOWN